Use Of Erlotinib In Advanced Non-Small Cell Lung Cancer Guided By New Analysis
4/19/2012
Patients with advanced non-small cell lung cancer should only receive treatment with the drug erlotinib before receiving standard chemotherapy if their tumor is known to harbor EGFR mutations, researchers report at the 3rd European Lung Cancer Conference in Geneva, Switzerland...
Paving Way For Testing Therapy That Combines Brain Cancer Vaccine With The Drug Avastin
4/19/2012
A new brain cancer vaccine tailored to individual patients by using material from their own tumors has proven effective in a multicenter phase 2 clinical trial at extending their lives by several months or longer. The patients suffered from recurrent glioblastoma multiforme - which kills thousands of Americans every year...
Swallowing Exercises Help Head And Neck Cancer Patients, Short-Term
4/18/2012
The April issue of Archives of Otolaryngology - Head & Neck Surgery reports that patients who undergo chemoradiation therapy (CRT), who perform specific swallowing exercises after their CRT, experience a short-term improvement in swallowing...
Cancer Pain Frequently Undertreated, Especially Among Minorities
4/18/2012
Researchers from The University of Texas MD Anderson Cancer Center have found that over 33.3% of individuals suffering from invasive cancer do not receive sufficient pain medication, with minorities twice as likely not to receive analgesics...
Prostate Cancer And Radiation Therapies - The Need For Additional Treatments
4/18/2012
In the April 18 issue of JAMA, a study comparing traditional radiation therapy to treat localized prostate cancer with intensity-modulated radiation therapy (IMRT) and proton therapy reveals thats IMRT was linked to fewer gastrointestinal side effects, receipt of additional cancer treatments and hip fractures but to more erectile dysfunction, whilst those who received proton ...
Treatment Of Gynecologic Cancers Reduced From 5 Weeks To 3 Days Using New Radiation Therapy
4/18/2012
About 71,500 women in the United States are diagnosed with a gynecologic cancer every year, according to the Centers for Disease Control. Researchers from University Hospitals Case Medical Center have developed a more effective way to treat gynecologic cancers, shortening radiation treatment time from five weeks to three days...
Balancing Trastuzumab's Survival Benefits And Heart Risks For Women With Breast Cancer
4/18/2012
Adding trastuzumab (trade name Herceptin) to the treatment offered to women who have HER2-positive breast cancer, significantly increases the chance of life being prolonged, and reduces the chance of tumours reappearing once therapy stops...
Study Finds Cancer Related Pain Often Under-Treated
4/18/2012
More than one third of patients with invasive cancer are undertreated for their pain, with minorities twice as likely to not receive analgesics, according to research from The University of Texas MD Anderson Cancer Center. The study, published in Journal of Clinical Oncology, is the largest prospective evaluation of cancer pain and related symptoms ever conducted in an outpatient setting...
Cancer Gene MCL1 Targeted
4/18/2012
A research team pursuing one of the most commonly altered genes in cancer has laid a critical foundation for understanding this gene that could point the way toward developing drugs against it. A recent study of cancer genetics pointed to the gene MCL1, which encodes a protein that helps keep cells alive...
Deterioration In A Husband's Health Likely When Wife Suffers Breast Cancer
4/18/2012
Caring for a wife with breast cancer can have a measurable negative effect on men's health, even years after the cancer diagnosis and completion of treatment, according to recent research. Men who reported the highest levels of stress in relation to their wives' cancer were at the highest risk for physical symptoms and weaker immune responses, the study showed...